Skip to content

Krystal Biotech

US · KRYS #1515 by market cap Listed 2017
308.89 -6.93 -2.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Citi moved from Hold to Buy on 2026-01-06.

Analyst consensus 6 analysts

Buy
Avg price target 393.17 +27.3%
Price target rangecurrent 308.89
Low361.00
Avg393.17
High441.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-06 RBC Capital -- Buy 375.00
2026-11-03 TD Cowen -- Buy 380.00
2026-11-03 Citi -- Buy 412.00
2026-11-02 BofA Securities -- Buy 390.00
2026-11-02 Citi -- Buy 412.00
2026-11-02 H.C. Wainwright -- Buy 361.00
2026-11-02 RBC Capital -- Buy 375.00
2026-10-21 TD Cowen -- Buy 403.00
2026-10-16 Citi -- Buy 416.00
2026-10-15 Citi -- Buy 416.00
2026-10-15 H.C. Wainwright -- Buy 361.00
2026-10-08 RBC Capital -- Buy 400.00
2026-09-24 Goldman Sachs -- Buy 441.00
2026-09-21 BofA Securities -- Buy 400.00
2026-08-14 RBC Capital -- Buy 400.00
2026-08-11 Wolfe Research -- Hold --
2026-08-04 Citi -- Buy 386.00
2026-08-03 TD Cowen -- Buy 403.00
2026-08-03 William Blair -- Buy --
2026-08-03 BofA Securities -- Buy 392.00
2026-08-03 H.C. Wainwright -- Buy 361.00
2026-07-22 William Blair -- Buy --
2026-07-13 BofA Securities -- Buy 396.00
2026-07-13 Jefferies -- Buy 474.00
2026-06-18 TD Cowen -- Buy 403.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-01-06 Citi Hold → Buy 309.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-02 -- ±8.92% -10.95% (beat)
2026/Q2 2026-08-03 -- ±10.66% -8.37% (in line)
2026/Q1 2026-05-04 -- ±8.29% +7.86% (in line)
2025/Q4 2026-02-17 -- ±8.15% +4.12% (in line)
2025/Q3 2025-11-03 -- ±11.42% +0.17% (in line)
2025/Q2 2025-08-04 -- ±11.51% -14.04% (beat)
2025/Q1 2025-05-06 -- ±11.04% -14.06% (beat)
2024/Q4 2025-02-19 -- ±13.26% +12.43% (in line)
2024/Q3 2024-11-04 -- ±13.93% -3.14% (in line)
2024/Q2 2024-08-05 -- ±15.03% -5.85% (in line)
2024/Q1 2024-05-06 -- ±13.03% -2.58% (in line)
2023/Q4 2024-02-26 -- ±16.98% +41.02% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Krystal Biotech discussion 0 comments

Add a comment